No spam - just the good stuff

Subscribe to our newsletter

News

Economy

Senescence in a dish: SENS launches first experiment.com campaign

ARDD 2023: It’s time to make longevity biotechnology credible

It’s a brave new world – but longevity needs to stay in the realm of the credible

ARDD Conference Chairs Alex Zhavoronkov and Morten Scheibye-Knudsen talk megatrends, altruism and longevity.

Senotherapeutics summit set to pioneer advancements in longevity research

Collaboration trumps competition: Building a strong longevity investment ecosystem together

Corinthia London launches partnership with London Regenerative Institute

Summit set to unite longevity startups, investors and researchers

Investing in Longevity 101

World’s first public hospital longevity clinic unveiled in Israel

SIRT6-focused biotech cements longevity focus with heavyweight appointment

Zuzalu: a pop-up city with longevity at its heart

Hevolution Foundation announces $115 million Geroscience Research Opportunities Awards

‘This conference is going to be the best yet’

Academy for Health and Lifespan Research announces 2023 inductees

Applications open for Maximon Longevity Prize 2023

Hevolution and AFAR announce recipients of Aging Biology and Geroscience Awards

Longevity Investors Conference to showcase promising startups to high-net-worth investors

King’s College and the LSF partner to advance human longevity education and research

Improving longevity literacy – and why digital health is the answer

New alliance forms to deliver tech-driven, personalized, preventive longevity solutions

Longevity is ‘Pivotal’ to accelerating social progress

UK MHRA to streamline clinical trial approvals in significant overhaul of trial regulation

New Hevolution Foundation Scientific Advisory Panel set to leverage geroscience expertise

Enhancing research development and education for healthy longevity

Health organisations petition FDA to reverse its position on NMN supplements

How the longevity industry can deliver lives that are healthier – physically and mentally

Off the shelves: Amazon bans NMN products

Formation of Longevity Science Caucus announced

Longevity Summit Dublin 2023 set to be focus for longevity and healthspan research and investment

£4m Longitude Prize on Dementia bags 175 entries

Elysium Health adds nine systems to its biological age test and launches aging research center

Global longevity investment hit $5.2 billion in 2022

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.